Annual Report 2010/11 - Sonova

Financial year Plan participants Grant date/
Expiry date
Granted Exercise
price
CONSOlIDATED FINANCIAl STATEMENTS 141
Vesting conditions Outstanding Average
remaining
life (years)
Exercisable
2008/09 WARs granted to key
Cash-settled employees in the USA1) 01.02.2009
4 equal tranches,
vest annually over
28.02.2014 38,180 56.00
4 years 23,590 2.9 4,500
Warrants granted to
4 equal tranches,
2009/10
BoD, MB and key 01.02.2010
vest annually over
Equity-settled
employees 28.02.2015 417,640 131.00
4 years 375,040 3.9 104,185
2009/10 WARs granted to key
Cash-settled employees in the USA1) 4 equal tranches,
01.02.2010
vest annually over
28.02.2015 34,500 131.00
4 years 34,500 3.9 8,625
WARs granted to key
2009/10
employees of
Cash-settled Advanced Bionics 1)
2 equal tranches,
01.01.2010
vest annually after
30.12.2013 65,392 125.80
2 years 47,892 2.8
Warrants granted to
4 equal tranches,
2010/11
BoD, MB and key 01.02.2011
vest annually over
Equity-settled
employees 29.02.2016 556,530 118.40
4 years 418,715 4.9
2010/11 WARs granted to key
Cash-settled employees in the USA1) 4 equal tranches,
01.02.2011
vest annually over
29.02.2016 55,535 118.40
4 years 55,535 4.9
Total 3,045,176 105.792) 1,929,751 3.2 672,4923) 1) For better comparison with options issued, the number of warrants has been adjusted by factor 25, as 25 warrants qualify for one share. The warrants are
tradable at the SIX Swiss Exchange. The ticker symbols are as follows: plan 2007/08: SONlT, plan 2008/09: SONAR, plan 2009/10: SONAB, plan Advanced
Bionics 2009/10: SONNA, plan 2010/11: SONCA.
2) Weighted average exercise price of outstanding options/warrants/WARs/SARs amounts to CHF 96.46.
3) Weighted average exercise price for exercisable options/warrants/WARs/SARs amounts to CHF 94.82.